Hypoglycemia

Published on 23/06/2015 by admin

Filed under Complementary Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 2.5 (38 votes)

This article have been viewed 6825 times

Chapter 176 Hypoglycemia

image Introduction

Both low and high blood glucose levels can cause significant physiologic dysfunction. Normally, the body maintains blood sugar levels within a narrow range through the coordinated effort of several glands and their hormones. If these control mechanisms are disrupted, hypoglycemia (low blood sugar) or diabetes (high blood sugar) may result.

The beta cells of the pancreas respond to the rise in blood glucose levels after meals by secreting the hormone insulin, which lowers blood glucose by increasing the rate that glucose is taken up by cells throughout the body. Reductions in blood glucose, as occur during food deprivation or exercise, cause the release of the hormone glucagon by the alpha cells of the pancreas. Glucagon stimulates the release of glucose stored in body tissues as glycogen, especially the liver. Rapidly falling blood sugar levels, anger, fright, and stress may stimulate the release of epinephrine and corticosteroids by the adrenal glands. These hormones provide a quicker breakdown of stored glucose for extra energy during a crisis or increased need.

Americans overstress these control mechanisms through improper diet and lifestyle. As a result, diabetes and hypoglycemia are common diseases.

Hypoglycemia is divided into two main categories: reactive hypoglycemia and fasting hypoglycemia. Reactive hypoglycemia, the most common, is characterized by the development of symptoms of hypoglycemia 3 to 5 hours after a meal and may herald the onset of early type II diabetes. Gastric surgeries may induce this condition,1 and anorexia nervosa has been a reported to be cause in the literature.2 Reactive hypoglycemia may also result from the use of oral hypoglycemic drugs. These sulfa drugs (sulfonylureas) appear to stimulate the secretion of additional insulin by the pancreas as well to as enhance the sensitivity of body tissues to insulin. Common examples of this class of drugs are listed in Box 176-1.

Some researchers, however, recommend that for many patients, this syndrome instead be designated idiopathic postprandial syndrome because, although symptoms do exist and are related to rapid drops in blood glucose, the absolute glucose levels are not reliable indicators of the syndrome. Many asymptomatic controls have glucose levels below 50, while many symptomatic patients have normal postprandial glucose levels.35

Fasting hypoglycemia is rare, because it usually appears only in severe disease states such as pancreatic tumors, extensive liver damage, prolonged starvation, autoantibodies against insulin or its receptor, various cancers, or as a result of excessive exogenous insulin in diabetic patients. Pregnant diabetic women using insulin or oral glycemic medications also have a high incidence of asymptomatic hypoglycemic events.6

Hypoglycemia can promote untoward physiologic changes in the body. Insulin-induced hypoglycemia is known to increase the levels of C-reactive protein, a known cardiac risk factor.7 Because glucose is the primary fuel for the brain, low levels affect the brain first. Symptoms of hypoglycemia can range from mild to severe, including the following:

image Diagnostic Considerations

Clinical hypoglycemia is identified by modified Whipple’s criteria consisting of (1) central nervous system symptoms including confusion, aberrant behavior, or coma; (2) a simultaneous blood glucose level equal to or less than 40 mg/dL; and (3) relief of these symptoms by the administration of glucose.1 The normal fasting blood glucose level is between 65 and 100 mg/dL. A fasting plasma blood glucose measurement greater than 126 mg/dL on two separate occasions is diagnostic of diabetes.8 Although the most specific criterion for the presence of hypoglycemia is a blood glucose level of 40 mg/dL or less, a blood glucose level below 50 mg/dL should arouse clinical suspicion.1

A more functional test of blood sugar control is the oral GTT. It is used in the diagnosis of both reactive hypoglycemia and diabetes, although it is rarely required for the latter. After fasting for at least 12 hours, a baseline blood glucose measurement is made. Then the subject is given a liquid containing glucose to drink. The amount consumed is based on body weight: 1.75 g/kg. Blood sugar levels are measured at 30 minutes, 1 hour, and then hourly for up to 6 hours. Basically blood sugar levels greater than 200 mg/dL indicate diabetes. Levels below 50 mg/dL indicate reactive hypoglycemia. Table 176-1 explains in detail how to interpret the results of a GTT.

TABLE 176-1 Criteria of Response to the Glucose Tolerance Test

Diagnosis Response
Normal No elevation >200 mg
<200 mg at the end of the first hour
<140 mg at the end of the second hour
Never <20 mg below fasting
Flat No variation more than ± 20 mg from fasting value
Prediabetic >140 mg at the end of the second hour
Diabetic ≥200 mg at the end of the second hour
Reactive hypoglycemia A normal 2- or 3-hour response curve, followed by a decrease of ≥20 mg from the fasting level during the final hours
Probable reactive hypoglycemia A normal 2- or 3-hour response curve, followed by a decrease of 10-20 mg from the fasting level during the final hours
Flat hypoglycemia An elevation of >20 mg, followed by a decrease of ≥20 mg below the fasting level
Prediabetic hypoglycemia A 2-hour response identical to the hypoglycemic prediabetic response but showing a hypoglycemic response during the final 3 hours
Hyperinsulinism A marked hypoglycemic response with a value of <50 mg during the third, fourth, or fifth hour

The Glucose-Insulin Tolerance Test

Relying on blood sugar levels alone is often not enough to diagnose hypoglycemia, because it is now widely recognized that the signs and symptoms of hypoglycemia can occur in individuals having blood glucose levels well above 50 mg/dL and there is a wide overlap between symptomatic patients and asymptomatic controls.3 Many of the symptoms linked to hypoglycemia appear to be the result of increases in insulin or epinephrine. Therefore, it has been recommended that insulin or epinephrine (adrenaline) be measured during a GTT because symptoms often correlate better with elevations in these hormones than with glucose levels.9,10 Several studies have shown that the glucose-insulin tolerance test (G-ITT) leads to a greater sensitivity in the diagnosis of both hypoglycemia and diabetes than the standard GTT.10,11

The G-ITT uses a standard 6-hour GTT coupled with measurements of insulin levels. The G-ITT appears to be one of the best diagnostic indicators for faulty sugar metabolism.11 As many as two thirds of subjects with suspected diabetes or hypoglycemia who have normal GTTs will demonstrate abnormal insulin tolerance tests. Table 176-2 lists the various patterns seen with the G-ITT.

TABLE 176-2 Criteria for the Glucose-Insulin Tolerance Test

PATTERN RESPONSE
Pattern 1 Normal fasting insulin 0-30 units. Peak insulin at 0.5-1 hour. The combined insulin values for the second and third hours is <60 units. This pattern is considered normal.
Pattern 2 Normal fasting insulin. Peak at 0.5-1 hour with a “delayed return to normal.” Second- and third-hour levels between 60 and 100 units are usually associated with hypoglycemia and are considered borderline for diabetes; values >100 units considered definite diabetes.
Pattern 3 Normal fasting insulin. Definite diabetes.
Pattern 4 High fasting insulin. Definite diabetes.
Pattern 5 Low insulin response. All tested values for insulin < 30. If this response is associated with elevated blood sugar levels, it probably indicates insulin-dependent diabetes (“juvenile pattern”).

The downside to this test is that it tends to be costly. For example, the G-ITT costs around $200, whereas a standard GTT is usually less than $30.

24-Hour Continuous Glucose Monitoring

Continuous glucose monitors (CGMs) are electronic diagnostic systems that require the insertion of a sensing catheter under the skin of the patient’s abdomen. The catheter contains a miniaturized electronic device that measures blood sugar and then sends this information every few seconds to a pager-sized computer module worn on the patient’s belt for up to a week. The portable computer module translates and records blood sugar data, which can then be downloaded to a larger computer. A graph showing the average blood sugar reading every 5 minutes (288 blood sugar readings per day) can then be generated and studied in relation to food intake, appetite, food cravings, hypoglycemic symptoms, medication, and exercise. CGMs have been shown to be very useful tools in the diagnosis and monitoring of blood sugar control.12,13

Using a CGM, Michael R. Lyon, MD, has discovered that most people with weight problems and insulin resistance go through their days with remarkably fluctuating blood sugar, or increased glycemic volatility. Rather than the absolute glucose level being the prime determinant of hypoglycemic symptoms, Lyon has found that feelings of hypoglycemia occur when the blood sugar drops rapidly, even when it was above the normal range (i.e., between 70 and 100 mg/dL) (Figure 176-1). In such cases, symptoms of hypoglycemia can range from mild to severe and include such things as food cravings, headache, depression, anxiety, irritability, blurred vision, excessive sweating, and mental confusion.

Rather than referring to these patients as suffering from hypoglycemia, Lyon and Michael T. Murray, ND, propose that they suffer from a new clinical entity they refer to as “elevated glycemic volatility.”63 These authors also believe that such volatility is at the heart of most weight problems. Their data indicate that rapidly fluctuating blood sugar levels are generally related to some degree of insulin resistance and made worse by more than moderate consumption of foods with a high glycemic impact.

image General Considerations

In the 1970s, hypoglycemia was a popular “self-diagnosis” for a long list of symptoms; every symptom on the questionnaire in Table 176-3 was linked to hypoglycemia. Although all of these symptoms may be due to hypoglycemia, there are obviously other causes in many cases. The tremendous public interest in hypoglycemia and sugar intake was fueled by a number of popular books like Sugar Blues, by William Duffy; Hope for Hypoglycemia, by Broda Barnes; and Sweet and Dangerous, by John Yudkin. The popularity of these books and the diagnosis of hypoglycemia were met with much skepticism from the medical community. Editorials in the Journal of the American Medical Association and the New England Journal of Medicine during the 1970s denounced this public interest in hypoglycemia and tried to invalidate the concept.14,15

Research in the past 15 years has provided an ever-increasing amount of information concerning the roles that refined carbohydrates and the faulty control of blood sugar play in many disease processes. New terminology and descriptions are now used to describe the complex hormonal fluxes that are largely a result of ingesting too many refined carbohydrates. For example, the term metabolic syndrome or syndrome X has been introduced to describe a cluster of abnormalities that owe their existence largely to a high intake of refined carbohydrates, leading to the development of hypoglycemia, excessive insulin secretion, and glucose intolerance followed by diminished insulin sensitivity and leading to high blood pressure, elevated cholesterol levels, obesity, and, ultimately, type 2 diabetes. Metabolic syndrome is discussed in greater detail later.

Hypoglycemia, or idiopathic postprandial syndrome, is without question a valid clinical entity. A substantial amount of information indicates that hypoglycemia is caused by an excessive intake of refined carbohydrates.16,17 Although most medical and health organizations as well as the U.S. government have recommended that no more than 10% of the total caloric intake be derived from refined sugars added to foods, added sugar accounts for roughly 30% of the total calories consumed by most Americans.18 The average American consumes more than 100 lb of sucrose and 40 lb of high-fructose corn syrup each year. This sugar addiction plays a major role in the high prevalence of ill health and chronic disease in the United States.

Health Impacts of Hypoglycemia

Aggressive and Criminal Behavior

A strong yet controversial link exists between hypoglycemia and aggressive or criminal behavior. Several controlled studies among psychiatric patients and habitually violent and impulsive criminals have shown that reactive hypoglycemia (as determined by an oral GTT) is a common finding.21,22 Furthermore, during the GTT, abnormal and sometimes emotionally explosive behavior is often observed. In one study, reactive hypoglycemia was shown to induce fire-setting behavior in arsonists.23

Several large studies involving more than 6000 inmates in 10 correctional institutions in three states have now evaluated the effect of dietary intervention (i.e., the elimination of refined sugar) on antisocial or aggressive behavior.24,25

In the first study, 174 incarcerated juvenile delinquents were placed on a sugar-restricted diet while another 102 offenders were placed on a control diet.24 During the 2-year study, the incidence of antisocial behavior was reduced by 45% in the treatment group. The most significant changes were in the reduction of assaults (83%), theft (77%), “horseplay” (65%), and refusal to obey orders (55%). Antisocial behavior changed most in those charged with assault, robbery, rape, aggravated assault, auto theft, vandalism, child molestation, arson, and possession of a deadly weapon.

In the largest study, 3999 incarcerated juveniles were studied over a period of 2 years.25 This study limited the dietary revisions to replacing sugary soft drinks with fruit juices and high-sugar snacks with nonrefined carbohydrate snacks (e.g., replacing a candy bar with popcorn). When the 1121 young men on the sugar-restricted diet were compared with the 884 on the control diet, there were significant differences: suicide attempts were reduced by 100%; the need for restraints to prevent self-injury was reduced by 75%; disruptive behavior was reduced by 42%; and assaults and fights were reduced by 25%. Interestingly, the dietary changes did not seem to affect the behavior of female subjects. This lack of effect seems to indicate that men and women may react to hypoglycemia differently. From an anthropologic and evolutionary view, this makes sense. Low blood sugar levels were undoubtedly an internal signal for men to hunt for food.

The link between hypoglycemia and aggressive behavior also extends to men without a history of criminal activity. In one study, a GTT was given to a group of men who did not have a history of aggressive behavior or hypoglycemia.17 In these subjects, a significant correlation was found between the tendency to become mildly hypoglycemic and scores on questionnaires used to measure aggression. The results indicate that aggressiveness often coincides with hypoglycemia.

Metabolic Syndrome

The term metabolic syndrome is used to describe a set of cardiovascular risk factors including glucose or insulin disturbances, high blood cholesterol and triglyceride levels, elevated blood pressure, and android obesity. Other terms to describe this syndrome include syndrome X, Reaven’s syndrome, insulin resistance syndrome, and atherothrombogenic syndrome.35,36

The underlying common metabolic denominator in the metabolic syndrome is an elevated insulin level along with insulin resistance. There is little doubt about what contributes to these elevations: an elevated intake of refined carbohydrates. An increased intake of simple sugar leads first to hypoglycemia and later to diabetes. There now exists considerable scientific evidence that the development of type 2 diabetes is preceded by elevations of serum insulin values and insulin insensitivity due to the prolonged consumption of refined sugars and the resulting elevations in insulin eventually lead to type 2 diabetes.45 In most cases these defects presented themselves decades before the development of diabetes.

Hypoglycemia, increased insulin secretion, metabolic syndrome, and type 2 diabetes can be viewed as a progression of the same illness—maladaptation to the Western diet. The human body was not designed to handle the amount of refined sugar, salt, saturated fats, and other harmful food compounds that many people in the United States and other Western countries feed it. The result is that a metabolic syndrome emerges—elevated insulin levels, obesity, elevated blood cholesterol and triglycerides, and high blood pressure.

image Therapeutic Considerations

Dietary Factors

Dietary carbohydrates play a central role in the cause, prevention, and treatment of hypoglycemia. Simple carbohydrates, or sugars, are quickly absorbed by the body, resulting in a rapid elevation in blood sugar and stimulating a corresponding excessive elevation in serum insulin levels. It is thought by some that the assortment of natural, simple sugars in fruits and vegetables has an advantage over sucrose and other refined sugars in that they are balanced by a wide range of nutrients that aid in the utilization of the sugars. However, of greater importance is the fact that in whole, unprocessed foods the sugars are more slowly absorbed, because they are contained within cells and are associated with fiber and other food elements.

Problems with carbohydrates begin when they are refined, which strips them of associated nutrients and increases their rate of absorption. Virtually all of the vitamin and trace mineral content has been removed from white sugar, white breads, pastries, and many breakfast cereals. When high-sugar foods are eaten alone, blood sugar levels rise quickly, producing a strain on blood sugar control. Eating foods high in simple sugars in any form (e.g., sucrose, honey, or maple syrup) is harmful to blood sugar control. Large amounts of fruit juice and even vegetable juice may be a problem for hypoglycemics, as the cell disruption characteristic of juicing increases the percentage of the sugars in the juices.

Currently, more than one half of the carbohydrates consumed in the United States are in the form of sugars added to processed foods as sweetening agents.18 Patients should be instructed to read food labels carefully for clues to sugar content. They should know that various words are used to describe refined simple carbohydrates; any of the following might appear on the label: sucrose, glucose, maltose, lactose, fructose, corn syrup, and white grape juice concentrate.

A Closer Look at Simple Carbohydrates

Glucose is not particularly sweet-tasting compared with fructose and sucrose. It is found in abundant amounts in fruits, honey, sweet corn, and most root vegetables. Glucose is also the primary repeating sugar unit of most complex carbohydrates.

Fructose or fruit sugar is the primary carbohydrate in many fruits, maple syrup, and honey. Fructose is very sweet, roughly 1.5 times sweeter than sucrose. Although fructose has the same chemical formula as glucose, its structure is quite different. In order to be used by the body, fructose must be converted to glucose within the liver.

Many physicians have recommended that individuals with diabetes or hypoglycemia avoid fruits and fructose. However, recent research challenges this. Fructose does not cause a rapid rise in blood sugar levels. Because fructose must be changed to glucose in the liver in order to be used by the body, blood glucose levels do not rise as rapidly with fructose consumption as they do with that of other simple sugars. For example, the ingestion of sucrose results in an immediate elevation in the blood sugar level. Although most diabetic and hypoglycemic individuals cannot tolerate sucrose, most can tolerate moderate amounts of fruits and fructose without loss of blood sugar control. In fact, fructose and fruits are not only much better tolerated than white bread and other refined carbohydrates but they also produce less sharp elevations in blood sugar levels compared with most sources of complex carbohydrates (starch).37 As a bonus, fructose at concentrations found in most single servings of fruit (e.g., 10 g) has actually been shown to enhance sensitivity to insulin.38

Regular fruit consumption also may help to control sugar cravings and promote weight loss in overweight individuals. Although studies have shown aspartame (NutraSweet), glucose, and sucrose to increase the appetite, fructose has actually been shown in several double-blind studies to decrease the calories and fat consumed. Typically, subjects are given food or drink containing an equivalent caloric amount of fructose or other sweetener 30 minutes to 2.5 hours before they are allowed to consume as much food as they want at a dinner buffet. Consistently, subjects receiving the fructose-sweetened food or drink consume substantially fewer calories and fat compared with the groups receiving aspartame, sucrose, or glucose.3941

The Glycemic Index and Glycemic Load

Two helpful methods of categorizing food on the basis of its ability to alter blood sugar are the glycemic index (GI) and the glycemic load (GL).

The GI was developed in 1981 to express the rise of blood glucose after a particular food is eaten.42 The standard value of 100 is based on the rise seen with the ingestion of glucose. The GI ranges from about 20 for fructose and whole barley, and to about 98 for a baked potato. The insulin response to carbohydrate-containing foods is similar to the rise in blood sugar.

The GI is used as a guideline for dietary recommendations for people with either diabetes or hypoglycemia (see Table 176-4). People with blood sugar problems are advised to avoid foods with high values and choose carbohydrate-containing foods with lower values. However, the GI should not be the only dietary guideline.

TABLE 176-4 Glycemic Index of Isocaloric Amounts of Some Common Foods

  FOOD GLYCEMIC INDEX
Sugars Fructose 20
Glucose 100
Honey 75
Maltose 105
Sucrose 60
Fruits Apples 39
Bananas 62
Orange juice 46
Oranges 40
Raisins 64
Vegetables Beets 64
Carrot, cooked 36
Carrot, raw 31
Potato, baked 98
Potato (new), boiled 70
Grains Bran cereal 51
Bread, white 69
Bread, whole grain 72
Corn 59
Corn flakes 80
Oatmeal 49
Pasta 45
Rice 70
Rice, puffed 95
Wheat cereal 67
Legumes Beans 31
Lentils 29
Peas 39
Other foods Ice cream 36
Milk 34
Nuts 13
Sausages 28

Modified from Truswell AS. Glycaemic index of foods. Eur J Clin Nutr 1992;46(suppl 2):S91-S101.

For example, high-fat foods like ice cream and sausage may have a low GI, but because a diet high in fat has been shown to impair glucose tolerance, these foods are not good choices for people with hypoglycemia or diabetes.

The GL uses the information the GI provides in a more comprehensive way to assess the impact of carbohydrate consumption.43 Although the GI reveals how quickly a particular food’s carbohydrate content can raise blood glucose levels, it still does not help us to understand how much of the blood sugar–increasing carbohydrate is in a certain food.

The dietary GL is defined as the value of a food’s GI divided by 100 and then multiplied by its available carbohydrate content. A GL of 20 or more is considered high, 11 to 19 is considered intermediate, and 10 or less is considered low. The GI of watermelon, for example, is 72, and a typical serving of 120 g has 6 g of available carbohydrate:

image

The point of this example is that even though the GI for watermelon is fairly high, its GL is low, indicating that within reasonable serving amounts, it does not adversely stress blood sugar control. For a complete listing of foods and their GI, fiber content, and GL, see Appendix 6.

The GL reinforces the idea that foods containing natural soluble and insoluble fibers as well as whole foods that are minimally processed remain better choices in terms of glycemic influence and insulin response.44

Further research indicates that diets with a high GL are directly linked to conditions such as diabetes45 and coronary heart disease46 as well as colon,47 ovarian,43 and pancreatic48 cancers.

The Importance of Fiber

Population studies as well as clinical and experimental data show blood sugar disorders to be clearly related to inadequate dietary fiber intake.18,49 These results indicate that although the intake of refined sugars should be curtailed, the intake of complex carbohydrate sources that are rich in fiber should be increased.

The term dietary fiber refers to the components of the plant cell wall as well as the indigestible residues from plant foods. Different types of fibers possess different actions. The water-soluble forms exert the most beneficial effects on blood sugar control. Included in this class are hemicelluloses, mucilages, gums, and pectins. These types of fiber are capable of the following actions:

For a full discussion of the importance of fiber, see Chapter 52.

The majority of fiber in most plant cell walls is water soluble. Particularly good sources of water-soluble fiber are legumes, oat bran, nuts, seeds, psyllium seed husks, pears, apples, and most vegetables. Patients should be advised to consume a large amount of plant food to obtain adequate levels of dietary fiber. A daily intake of 50 g is a healthful goal.

PolyGlycoPlex

Based on their work with CGM, Drs. Lyon and Murray have uncovered many important findings on how to effectively reduce blood sugar volatility. For example, they confirmed earlier work that although a low glycemic diet is very important in reducing blood sugar levels, it has little effect in eliminating blood sugar volatility.50 They have found that the most effective way to reduce glycemic volatility is a low glycemic diet along with the use of a novel matrix of soluble fibers known as PolyGlycoPlex (PGX). Several double-blind studies have shown a reduction of postprandial hypoglycemia by PGX in a dose-dependent manner, independent of food form.5153 The PGX matrix produces a higher level of viscosity, gel-forming properties, and expansion with water compared with any other known fiber. This translates to a significant reduction in the glycemic impact of any food or meal. The typical dosage is 1.5 to 5 g before meals.

Lifestyle Factors

Alcohol

Alcohol consumption severely stresses blood sugar control and is often a contributing factor to hypoglycemia. Alcohol induces reactive hypoglycemia by interfering with normal glucose utilization as well as increasing the secretion of insulin. The resultant drop in blood sugar produces a craving for food, particularly foods that quickly elevate blood sugar, as well as a craving for more alcohol. The increased sugar consumption aggravates the reactive hypoglycemia, particularly in the presence of more alcohol, again due to alcohol-induced impairment of normal glucose utilization and increased secretion of insulin.

Hypoglycemia is an important complication of acute and chronic alcohol abuse. Hypoglycemia aggravates the mental and emotional problems of the alcoholic and the withdrawing alcoholic with such symptoms as the following58:

Although acute alcohol ingestion induces hypoglycemia, in the long run it leads to hyperglycemia and diabetes. Eventually the body becomes insensitive to the augmented insulin release caused by the alcohol. In addition, alcohol itself can cause insulin resistance even in healthy individuals.59 There is also evidence from large population studies that alcohol intake is strongly correlated with diabetes.18,60 The higher the alcohol intake, the more likely it is that an individual will have or develop diabetes.

References

1. Pourmotabbed G., Kitabchi A.E. Hypoglycemia. Obstet Gynecol Clin North Am. 2001;28:383–400.

2. Yasuhara D., Deguchi D., Tsutsui J., et al. A characteristic reactive hypoglycemia induced by rapid change of eating behavior in anorexia nervosa: a case report. Int J Eat Disord. 2003;34:273–277.

3. Chalew S.A., Koetter H., Hoffman S., et al. Diagnosis of reactive hypoglycemia: pitfalls in the use of the oral glucose tolerance test. South Med J. 1986;79:285–287.

4. Palardy J., Havrankova J., Lepage R., et al. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglycemia. N Engl J Med. 1989;321:1421–1425.

5. Kwentus J.A., Achilles J.T., Goyer P.F. Hypoglycemia etiologic and psychosomatic aspects of diagnosis. Postgrad Med. 1982;71:99–104.

6. Yogev Y., Ben-Haroush A., Chen R., et al. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol. 2004;104:88–93.

7. Galloway P.J., Thomson G.A., Fisher B.M., et al. Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care. 2000;23:861–862.

8. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: Department of Non-communicable Disease Surveillance; 1999.

9. Chalew S.A., McLaughlin J.V., Mersey J.H., et al. The use of the plasma epinephrine response in the diagnosis of idiopathic postprandial syndrome. JAMA. 1984;251:612–615.

10. Hadji-Georgopoulus A., Schmidt M.I., Margolis S., et al. Elevated hypoglycemic index and late hyperinsulinism in symptomatic postprandial hypoglycemia. J Clin Endocrinol Metab. 1980;50:371–376.

11. Fabrykant M. The problem of functional hyperinsulinism on functional hypoglycemia attributed to nervous causes. 1. Laboratory and clinical correlations. Metabolism. 1955;4:469–479.

12. Gross T.M., Mastrototaro J.J. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther. 2000;2(suppl 1):S19–S26.

13. Sabbah H., McCulloch K., Frederickson L., et al. Detailed Data from a Continuous Glucose Monitoring System (CGMS) facilitates comprehensive diabetes management recommendations. Diabetes. 2000;49(suppl 1):718.

14. No authors. Statement on hypoglycemia. JAMA. 1973;223:682.

15. Cahill G.F., Jr., Soeldner J.S. A non-editorial on non-hypoglycemia. N Engl J Med. 1974;291:905–906.

16. Hofeldt F.D. Patients with bona fide meal-related hypoglycemia should be treated primarily with dietary restriction of refined carbohydrate. Endocrinol Metab Clin North Am. 1989;18:185–201.

17. Sanders L.R., Hofeldt F.D., Kirk M.C., et al. Refined carbohydrate as a contributing factor in reactive hypoglycemia. South Med J. 1982;75:1072–1075.

18. National Research Council. Diet and health: implications for reducing chronic disease risk. Washington, DC: National Academy Press; 1989.

19. Winokur A., Maislin G., Phiillips J.L., et al. Insulin resistance after glucose tolerance testing in patients with major depression. Am J Psychiatry. 1988;145:325–330.

20. Wright J.H., Jacisin J.J., Radin N.S., et al. Glucose metabolism in unipolar depression. Br J Psychiatry. 1978;132:386–393.

21. Schauss A.G. Nutrition and behavior: complex interdisciplinary research. Nutr Health. 1984;3:9–37.

22. Benton D. Hypoglycemia and aggression: a review. Int J Neurosci. 1988;41:163–168.

23. Virkkunen M. Reactive hypoglycemic tendency among arsonists. Acta Psychiatr Scand. 1984;69:445–452.

24. Schoenthaler S.J. Diet and crime: an empirical examination of the value of nutrition in the control and treatment of incarcerated juvenile offenders. Int J Biosocial Res. 1983;4:25–39.

25. Schoenthaler S.J. The northern California diet-behavior program: an empirical evaluation of 3,000 incarcerated juveniles in Stanislaus County Juvenile Hall. Int J Biosocial Res. 1983;5:99–106.

26. Abraham G.E. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med. 1983;28:446–464.

27. Walsh C.H., O’Sullivan D.J. Studies of glucose tolerance, insulin and growth hormone secretion during the menstrual cycle in healthy women. Ir J Med Sci. 1975;144:18–24.

28. Critchley M. Migraine. Lancet. 1933;1:123–126.

29. Dexter J.D., Roberts J., Byer J.A. The five hour glucose tolerance test and effect of low sucrose diet in migraine. Headache. 1978;18:91–94.

30. Mykkanen L., Laakso M., Pyorala K. High plasma insulin levels associated with coronary heart disease in the elderly. Am J Epidemiol. 1993;137:1190–1202.

31. Yudkin J. Metabolic changes induced by sugar in relation to coronary heart disease and diabetes. Nutr Health. 1987;5:5–8.

32. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131–141.

33. Bansal S., Toh S.H., LaBresh K.A. Chest pain as a presentation of reactive hypoglycemia. Chest. 1983;84:641–642.

34. Hanson M., Bergentz S.E., Ericsson B.F., et al. The oral glucose tolerance test in men under 55 years of age with intermittent claudication. Angiology. 1987;38:469–473.

35. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven’s syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol. 1992;20:S5–S10.

36. Maseri A. Syndrome X. Still an appropriate name. J Am Coll Cardiol. 1991;17:1471–1472.

37. Gregersen S., Rasmussen O., Larsen S., et al. Glycaemic and insulinaemic responses to orange and apple compared with white bread in non-insulin dependent diabetic subjects. Eur J Clin Nutr. 1992;46:301–303.

38. Koivisto V.A., Yki-Jarvinen H. Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med. 1993;233:145–153.

39. Rodin J. Effects of pure sugar vs. mixed starch fructose loads on food intake. Appetite. 1991;17:213–219.

40. Rodin J. Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake. Am J Clin Nutr. 1990;51:428–435.

41. Spitzer L., Rodin J. Effects of fructose and glucose preloads on subsequent food intake. Appetite. 1987;8:135–145.

42. Jenkins D.J., Wolever T.M., Taylor R.H., et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34:362–366.

43. Lukaczer D. Sweet, hot and deadly: the link between glycemic index, inflammation, and cardiovascular disease: evolving research and practical applications. Portland, OR: Proceedings of the American Association of Naturopathic Physicians 18th Annual Convention and Exposition; 2003.

44. Granfeldt Y., Eliasson A.C., Bjorck I. An examination of the possibility of lowering the glycemic index of oat and barley flakes by minimal processing. J Nutr. 2000;130:2207–2214.

45. Willett W., Manson J., Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76:274S–2780S.

46. Liu S., Willett W.C., Stampfer M.J., et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in U.S. women. Am J Clin Nutr. 2000;71:1455–1461.

47. Franceschi S., Dal Maso L., Augustin L., et al. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001;12:173–178.

48. Michaud D.S., Liu S., Giovannucci E., et al. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst. 2002;94:1293–1300.

49. Trowell H., Burkitt D.P. Western diseases: their emergence and prevention. Cambridge, MA: Harvard University Press; 1981.

50. Brynes A.E., Lee J.L., Brighton R.E., et al. A low glycemic diet significantly improves 24-h blood glucose profile in people with type 2 diabetes, as assessed using the continuous glucose MiniMed monitor [Letter to the Editor]. Diabetes Care. 2003;26:548–549.

51. Jenkins A.L., Kacinik V., Lyon M., et al. Effect of adding the novel fiber, PGX®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels: a randomized, controlled trial. Nutr J. 2010 Nov 22;9:58.

52. Brand-Miller J.C., Atkinson F.S., Gahler R.J., et al. Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia. Eur J Clin Nutr. 2010 Dec;64(12):1488–1493.

53. Jenkins A.L., Kacinik V., Lyon M.R., et al. Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form. J Am Coll Nutr. 2010 Apr;29(2):92–98.

54. Anderson R.A. Chromium, glucose tolerance, and diabetes. Biol Trace Elem Res. 1992;32:19–24.

55. Anderson R.A., Polansky M.M., Bryden N.A., et al. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism. 1987;36:351–355.

56. McCarty M.F. Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control. Med Hypoth. 1996;46:77–80.

57. Anderson R.A. Nutritional factors influencing glucose/insulin system: chromium. J Am Coll Nutr. 1997;16:404–410.

58. Wyngaarden J.B., Smith L.H., Bennett J.C. Cecil Textbook of Medicine. Philadelphia: WB Saunders, 1992.

59. Hirata Y. Diabetes and alcohol. Asian Med J. 1988;31:564–569.

60. Selby J.V., Newman B., King M.C., et al. Environmental and behavioral determinants of fasting plasma glucose in women: a matched co-twin analysis. Am J Epidemiol. 1987;125:979–988.

61. Vallerand A.L., Cuerrier J.P., Shapcott D., et al. Influence of exercise training on tissue chromium concentrations in the rat. Am J Clin Nutr. 1984;39:402–409.

62. Sato Y., Nagasaki M., Nakai N., et al. Physical exercise improves glucose metabolism in lifestyle-related diseases. Exp Biol Med (Maywood). 2003;228:1208–1212.

63. Murray M.T., Lyon M.R. Hunger Free Forever. New York: Atria; 2008.